Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
A randomized controlled open-label clinical trial of ursodeoxycholic acid combined with low
dose glucocorticoid in the treatment of PBC With AIH Features II to asses efficacy and
safety.